Terminated NA INTERVENTIONAL 2-arm NCT01753830

Durolane Versus Phosphate Buffered Saline (PBS) in Knee Osteoarthritis

A Multi Center, Randomized, Double Blind, Saline Controlled Study of a Single Injection of Durolane® Versus a Single Injection of Phosphate Buffered Saline (PBS) to Treat Pain Associated With Osteoarthritis of the Knee

Sponsor: Galderma R&D

Conditions Knee Osteoarthritis

Interventions Durolane PBS

Updated 10 times since 2017 Last updated: Aug 24, 2022 Started: Dec 31, 2012 Primary completion: Feb 28, 2014 Completion: Feb 28, 2014

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Terminated

Study terminated early due to decision by sponsor

Other terminated trials from Galderma R&D

See all terminations from Galderma R&D

Other Knee Osteoarthritis trials with similar outcome

Browse all Knee Osteoarthritis trials

This NA trial investigates Knee Osteoarthritis and is currently terminated or withdrawn. Galderma R&D leads this study, which shows 10 recorded versions since 2012 — indicating substantial longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

Change History

10 versions recorded

Sep 2024 — Present [monthly]

Terminated NA
Jul 2024 — Sep 2024 [monthly]

Terminated NA
Jan 2023 — Jul 2024 [monthly]

Terminated NA
Dec 2022 — Jan 2023 [monthly]

Terminated NA
Sep 2022 — Dec 2022 [monthly]

Terminated NA

▶ Show 5 earlier versions

Jan 2021 — Sep 2022 [monthly]

Terminated NA
Oct 2020 — Jan 2021 [monthly]

Terminated NA
Jun 2018 — Oct 2020 [monthly]

Terminated NA
Feb 2017 — Jun 2018 [monthly]

Terminated NA
Jan 2017 — Feb 2017 [monthly]

Terminated NA

First recorded

Dec 2012

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Galderma R&D

Data source: Galderma R&D

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

Anniston, United States , Beverly Hills, United States , Boise, United States , Boulder, United States , Charleston, United States , Danbury, United States , Duncansville, United States , El Cajon, United States , Evansville, United States , Hot Springs, United States and 15 more locations